Furthermore, in line with previous neuropathological studies of patients with ALS, all C9orf72 repeat expansion carrying patients and none of the patients with a SOD1 mutation had TDP-43 pathology at postmortem and neither TDP-43 severity nor cell-type distribution was associated with disease progression. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.